Scancell founder says the company is ready to commercialise novel medicines to counteract cancer. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Director/PDMR Shareholding

12 Nov 2012 10:53

RNS Number : 8779Q
Lupus Capital PLC
12 November 2012
 



LUPUS CAPITAL PLC

("Lupus" or "the Group" or "the Company")

 

Director's Dealing

 

The Company was today informed that Mr. Martin Towers, Non-Executive Director of the Company, acquired, through the Dividend Reinvestment Plan, 277 ordinary shares of 5p each in the Company for a price of 170p per share.

 

Following this purchase, Mr. Towers is interested in a total of 50,277 shares in the Company, representing 0.039% of the total issued share capital of the Company.

 

 

Enquiries:

 

 

 

Lupus Capital plc

 

+44 (0)20 7976 8000

 

Louis Eperjesi (CEO)

James Brotherton (CFO)

 

 

 

 

 

Canaccord Genuity (NOMAD)

 

+44 (0)20 7523 8350

 

 

12 November 2012

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
RDSFFDFSEFESEIF

Related Shares

Back to RNS

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.